Nahdi Medical Company (TADAWUL:4164)

Nahdi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	10,373	10,213	9,446	8,714	8,616	8,066
Revenue Growth (YoY)	5.59%	8.12%	8.41%	1.13%	6.82%	-6.67%
Cost of Revenue	6,637	6,521	6,025	5,278	5,141	4,821
Gross Profit	3,736	3,692	3,421	3,436	3,475	3,245
Selling, General & Admin	2,839	2,786	2,577	2,499	2,500	2,397
Other Operating Expenses	-19.14	-19.79	-27.91	-23.7	-24.3	-58.06
Operating Expenses	2,820	2,766	2,549	2,475	2,475	2,339
Operating Income	915.81	926.06	871.66	960.74	999.82	905.94
Interest Expense	-87.51	-88.01	-73.72	-50.46	-50.47	-78.88
Interest & Investment Income	44.6	48.76	50.8	56.82	12.13	2.96
Currency Exchange Gain (Loss)	11.37	11.37	8.34	7.91	1.8	-
Other Non Operating Income (Expenses)	-52.55	-52.75	-25.67	-31.47	-11.15	7.61
EBT Excluding Unusual Items	831.73	845.42	831.41	943.53	952.13	837.63
Gain (Loss) on Sale of Assets	0.49	0.49	1.54	0.22	-17.37	0.15
Asset Writedown	-	-	1.6	0.5	3.16	19.49
Pretax Income	832.43	845.91	834.54	944.25	937.93	857.27
Income Tax Expense	21.18	15.17	13.82	51.63	50.11	44.74
Net Income	811.26	830.74	820.72	892.62	887.81	812.53
Net Income to Common	811.26	830.74	820.72	892.62	887.81	812.53
Net Income Growth	-3.76%	1.22%	-8.05%	0.54%	9.26%	-4.31%
Shares Outstanding (Basic)	130	130	130	130	130	130
Shares Outstanding (Diluted)	130	130	130	130	130	130
EPS (Basic)	6.24	6.39	6.31	6.87	6.83	6.25
EPS (Diluted)	6.24	6.39	6.31	6.87	6.83	6.25
EPS Growth	-3.76%	1.22%	-8.05%	0.54%	9.26%	-4.31%
Free Cash Flow	992.35	746.64	1,152	962.17	1,418	1,051
Free Cash Flow Per Share	7.63	5.74	8.86	7.40	10.90	8.09
Dividend Per Share	5.600	5.600	5.500	5.500	5.310	-
Dividend Growth	1.82%	1.82%	-	3.58%	-	-
Gross Margin	36.02%	36.15%	36.21%	39.43%	40.33%	40.23%
Operating Margin	8.83%	9.07%	9.23%	11.03%	11.60%	11.23%
Profit Margin	7.82%	8.13%	8.69%	10.24%	10.30%	10.07%
Free Cash Flow Margin	9.57%	7.31%	12.19%	11.04%	16.45%	13.04%
EBITDA	1,210	1,215	1,130	1,181	1,192	1,070
EBITDA Margin	11.67%	11.90%	11.96%	13.55%	13.84%	13.26%
D&A For EBITDA	294.35	289.25	258.31	219.86	192.36	164.03
EBIT	915.81	926.06	871.66	960.74	999.82	905.94
EBIT Margin	8.83%	9.07%	9.23%	11.03%	11.60%	11.23%
Effective Tax Rate	2.54%	1.79%	1.66%	5.47%	5.34%	5.22%
Advertising Expenses	-	52.94	59.61	66.36	67.81	54.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.